{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:25:56Z","timestamp":1789453556019,"version":"build-2803163510"},"reference-count":16,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDS"],"published-print":{"date-parts":[[2020,6,19]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Lamotrigine is a phenyltriazine medication that has been approved by the\nUnited States Food and Drug Administration as monotherapy and as an adjunctive agent for the\ntreatment of seizure disorder. It was later approved by the FDA for the treatment of bipolar disorder.\nLamotrigine is generally well tolerated by patients, but some serious symptoms can occur during\ntreatment. These severe side effects include rashes and multi-organ failure. Lamotrigine has also\nbeen associated with the development of mental status changes, frequently when used concurrently\nwith other medications that may impact the metabolism of lamotrigine.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>To present the case of a 65-year-old man being treated with lamotrigine and valproic acid\nwho developed mental status changes after the addition of sertraline to his medication regimen,\nand to compare this case to existing cases reported in the literature.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Discussion:<\/jats:title>\n<jats:p>Our case adds to the existing literature by demonstrating that patients may experience\nadverse medication effects despite lamotrigine levels that are normally considered to be in the therapeutic\nrange, highlighting the importance of clinical correlation when obtaining medication levels.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Clinicians should use caution interpreting lamotrigine levels when working up delirium,\nas normal levels may not rule out the development of lamotrigine toxicity.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1574886315666200225111057","type":"journal-article","created":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T14:47:56Z","timestamp":1582642076000},"page":"156-159","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Delirium Secondary to Lamotrigine Toxicity"],"prefix":"10.2174","volume":"15","author":[{"given":"Deborah L.","family":"Sanchez","sequence":"first","affiliation":[{"name":"Mental Health and Behavioral Sciences Service, James A. Haley Veterans Hospital, Tampa, FL, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Fusick","sequence":"additional","affiliation":[{"name":"Mental Health and Behavioral Sciences Service, James A. Haley Veterans Hospital, Tampa, FL, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Gunther","sequence":"additional","affiliation":[{"name":"Mental Health and Behavioral Sciences Service, James A. Haley Veterans Hospital, Tampa, FL, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Hernandez","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Neurosciences, University of South Florida Morsani College of Medicine, Tampa, FL, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Sullivan","sequence":"additional","affiliation":[{"name":"Mental Health and Behavioral Sciences Service, James A. Haley Veterans Hospital, Tampa, FL, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Catalano","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Neurosciences, University of South Florida Morsani College of Medicine, Tampa, FL, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Catalano","sequence":"additional","affiliation":[{"name":"Mental Health and Behavioral Sciences Service, James A. Haley Veterans Hospital, Tampa, FL, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/ijms19072143","volume":"19","author":"L\u00f3pez-Mu\u00f1oz F.","year":"2018","unstructured":"L\u00f3pez-Mu\u00f1oz F.; Shen W.W.; D\u2019Ocon P.; Romero A.; \u00c1lamo C.; A History of the pharmacological treatment of bipolar disorder. Int J Mol Sci 2018,19(7),19","journal-title":"Int J Mol Sci"},{"key":"ref=2","first-page":"593","author":"Bauer L.A.","year":"2015","unstructured":"Bauer L.A.;  In Applied Clinical Pharmacokinetics 2015,593-610","journal-title":"In Applied Clinical Pharmacokinetics"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/bcp.12984","volume":"82","author":"Milosheska D.","year":"2016","unstructured":"Milosheska D.; Lorber B.; Vovk T.; Kastelic M.; Dol\u017ean V.; Grabnar I.; Pharmacokinetics of lamotrigine and its metabolite N-2-glucuronide: Influence of polymorphism of UDP-glucuronosyltransferases and drug transporters. Br J Clin Pharmacol 2016,82(2),399-411","journal-title":"Br J Clin Pharmacol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"60","DOI":"10.2174\/18715249113136660060","volume":"9","author":"Marrero-Gonzalez P.C.","year":"2014","unstructured":"Marrero-Gonzalez P.C.; Ruano O.L.; Catalano G.; Catalano M.C.; Dystonia associated with lamotrigine therapy: A case report and review of the literature. Curr Drug Saf 2014,9(1),60-62","journal-title":"Curr Drug Saf"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2174\/1574886311207040269","volume":"11","author":"Centorino M.B.","year":"2016","unstructured":"Centorino M.B.; Catalano G.; Catalano M.C.; Lamotrigine induced whole body tics: A case report and literature review. Curr Drug Saf 2016,11(2),189-191","journal-title":"Curr Drug Saf"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S1059-1311(98)80074-5","volume":"7","author":"Kaufman K.R.","year":"1998","unstructured":"Kaufman K.R.; Gerner R.; Lamotrigine toxicity secondary to sertraline. Seizure 1998,7(2),163-165","journal-title":"Seizure"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1176\/appi.ajp.2008.08020191","volume":"165","author":"Chistyakova Y.","year":"2008","unstructured":"Chistyakova Y.; Amos J.; Delirium associated with lamotrigine and fluoxetine treatment. Am J Psychiatry 2008,165(7),918-919","journal-title":"Am J Psychiatry"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1176\/appi.ajp.161.6.1128-a","volume":"161","author":"Mueller T.H.","year":"2004","unstructured":"Mueller T.H.; Beeber A.R.; Delirium from valproic acid with lamotrigine. Am J Psychiatry 2004,161(6),1128-1129","journal-title":"Am J Psychiatry"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/S0140-6736(96)91464-6","volume":"347","author":"Hennessy M.J.","year":"1996","unstructured":"Hennessy M.J.; Wiles C.M.; Lamotrigine encephalopathy. Lancet 1996,347(9006),974-975","journal-title":"Lancet"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1590\/S1516-44462008000100017","volume":"30","author":"Rocha F.F.","year":"2008","unstructured":"Rocha F.F.; Secondary delirium due to the use of lamotrigine with abrupt increase valproic acid\u2019s dose. Br J Psychiatry 2008,30(1),88","journal-title":"Br J Psychiatry"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1046\/j.1528-1157.2001.0420081082.x","volume":"42","author":"Sbei M.","year":"2001","unstructured":"Sbei M.; Campellone J.V.; Stupor from lamotrigine toxicity. Epilepsia 2001,42(8),1082-1083","journal-title":"Epilepsia"},{"key":"ref=12","unstructured":"Lamotrigine serum level information sheet. Available from:"},{"key":"ref=13","first-page":"FR01","volume":"9","author":"Muraleedharan A.","year":"2015","unstructured":"Muraleedharan A.; Palappallil D.S.; Gangadhar R.; Das S.; Valproate induced hyperammonemic delirium. J Clin Diagn Res 2015,9(12),FR01-FR03","journal-title":"J Clin Diagn Res"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nrneurol.2009.24","volume":"5","author":"Fong T.G.","year":"2009","unstructured":"Fong T.G.; Tulebaev S.R.; Inouye S.K.; Delirium in elderly adults: Diagnosis, prevention and treatment. Nat Rev Neurol 2009,5(4),210-220","journal-title":"Nat Rev Neurol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/j.1365-2125.1992.tb04079.x","volume":"33","author":"Yuen A.W.","year":"1992","unstructured":"Yuen A.W.; Land G.; Weatherley B.C.; Peck A.W.; Sodium valproate acutely inhibits lamotrigine metabolism. Br J Clin Pharmacol 1992,33(5),511-513","journal-title":"Br J Clin Pharmacol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1535-7511.2005.05303.x","volume":"5","author":"Abou-Khalil B.W.","year":"2005","unstructured":"Abou-Khalil B.W.; Making sense of lamotrigine serum levels. Epilepsy Curr 2005,5(3),115","journal-title":"Epilepsy Curr"}],"container-title":["Current Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/179712","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/179712\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/179712","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T17:05:12Z","timestamp":1626195912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/179712\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,19]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,6,19]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1574886315666200225111057","relation":{},"ISSN":["1574-8863"],"issn-type":[{"value":"1574-8863","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,19]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-11-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}